Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

Robotic electrophysiology operating room including Stereotaxis Genesis RMN and Stereotaxis Imaging Model S systems. Image courtesy of Stereotaxis.

News | Robotic Systems | May 09, 2019

May 9, 2019 – Stereotaxis introduced Stereotaxis Genesis RMN, its next-generation...

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
News | EP Mapping and Imaging Systems | May 09, 2019

May 9, 2019 — Philips announced a collaboration with Medtronic to further advance treatment of...

Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019

May 8, 2019 — Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new...

Khaldoon Alaswad, M.D., FSCAI, right, during a chronic total occlusion (CTO) case in his lab at Henry Ford Hospital, Detroit. He is presenting in several SCAI 2019 sessions.  SCAI 2019 late breaking sessions, SCAI featured research sessions.

Khaldoon Alaswad, M.D., FSCAI, right, during a chronic total occlusion (CTO) case in his lab at Henry Ford Hospital, Detroit. He is presenting in several SCAI 2019 sessions.  

Feature | SCAI | May 08, 2019
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor

May 7, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...

Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, which can take 3-D datasets and the AI automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard views for an echocardiogram to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.

Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, where the AI takes 3-D datasets and automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard echocardiogram views to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.

Feature | Artificial Intelligence | May 07, 2019 | Ross Upton

Artificial Intelligence has a multitude of impacts on our daily lives, from recommending movies based upon your...

Philips Azurion Clarity angiography system in the hybrid cath lab at Henry Ford Hospital.
360 Photos | 360 View Photos | May 06, 2019

This is a 360 degree image showing the main hybrid cath lab at ...

FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic
Technology | Leads Implantable Devices | May 06, 2019

May 6, 2019 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad...

According to the National Association of County and City Health Officials, only 33 percent of the organizations plan against cybersecurity threats and initiate patient identity protection protocols.

According to the National Association of County and City Health Officials, only 33 percent of the organizations plan against cybersecurity threats and initiate patient identity protection protocols. 

Feature | Cybersecurity | May 06, 2019 | Maxim Chernyak

As the...

Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor
News | Implantable Cardiac Monitor (ICM) | May 06, 2019

May 6, 2019 — Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive...

Illustration showing the self-expanding deployment of the Boston Scientific Vici venous stent in the iliofemoral vein.

Illustration showing the self-expanding deployment of the Vici stent in the iliofemoral vein. 

Technology | Venous Therapies | May 06, 2019

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System...

Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (Vyndamax) capsules for the treatment of the cardiomyopathy.

Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. 

Technology | Heart Failure | May 06, 2019

May 6, 2019 — The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (...

Overlay Init